[1] Second, combination therapy where practitioners use Calocurb alongside injectables at much lower doses (keeping tirzepatide at 2.5mg rather than increasing to 10mg), significantly reducing side effects and costs while combining exogenous and endogenous hormone stimulation Third, the post-cycle therapy for titrating off, which Sarah emphasizes isn't an "if" but a "must" -- people must use something to prevent the valley of death
This helps keep your weight stable and ensures long-term success without needing to keep increasing your dosage
Diabetes Res Clin Pract 174:108737 [DOI] [PubMed] [Google Scholar] Ke Z, Ma Q, Ye X, Wang Y, Jin Y, Zhao X et al (2024) Peptide GLP-1 receptor agonists: from injection to oral delivery strategies
Pang, Douglas W
When you inject semaglutide, it binds exclusively to GLP-1 receptors throughout your body
The DPP4 enzyme deactivates GLP1